263 related articles for article (PubMed ID: 9511196)
1. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
[TBL] [Abstract][Full Text] [Related]
2. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen.
Elhelw B; Ghorab MN; Farrag SH
Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051
[TBL] [Abstract][Full Text] [Related]
3. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
Hann LE; Gretz EM; Bach AM; Francis SM
AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
[TBL] [Abstract][Full Text] [Related]
4. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
5. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
6. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding.
Goldstein SR; Zeltser I; Horan CK; Snyder JR; Schwartz LB
Am J Obstet Gynecol; 1997 Jul; 177(1):102-8. PubMed ID: 9240591
[TBL] [Abstract][Full Text] [Related]
8. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
[TBL] [Abstract][Full Text] [Related]
9. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.
Fong K; Causer P; Atri M; Lytwyn A; Kung R
Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649
[TBL] [Abstract][Full Text] [Related]
10. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880
[TBL] [Abstract][Full Text] [Related]
11. Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
Timmerman D; Neven P; Deprest J; Konstantinović ML; Vergote I
Cancer; 2003 Jul; 98(2):431-2; author reply 432-3. PubMed ID: 12872366
[No Abstract] [Full Text] [Related]
12. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
13. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
[TBL] [Abstract][Full Text] [Related]
14. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
[TBL] [Abstract][Full Text] [Related]
15. [Value of saline infusion sonohysterography and hysteroscopy in postmenopausal patient with persistent abnormal ultrasonographic images after endometrial curettage with normal histological results].
Ludwin A; Pityński K; Szczudrawa A; Biernat I; Loster J
Ginekol Pol; 2003 Sep; 74(9):786-92. PubMed ID: 14674125
[TBL] [Abstract][Full Text] [Related]
16. Transvaginal sonography, saline contrast sonohysterography and hysteroscopy for the investigation of women with postmenopausal bleeding and endometrium > 5 mm.
Epstein E; Ramirez A; Skoog L; Valentin L
Ultrasound Obstet Gynecol; 2001 Aug; 18(2):157-62. PubMed ID: 11529998
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
18. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W
Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306
[TBL] [Abstract][Full Text] [Related]
19. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
[TBL] [Abstract][Full Text] [Related]
20. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.
Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I
Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
